Related Experiment Videos
Carboplatin hypersensitivity presenting as coronary vasospasm - a case report
Martin R Chasen1, Iftikar O Ebrahim
1Mary Potter Oncology Centre, Little Company of Mary Hospital, Groenkloof, Pretoria, Republic of South Africa. mrc@mpoc.co.za
Cancer Chemotherapy and Pharmacology
|November 20, 2002
Summary
Hypersensitivity to carboplatin chemotherapy can cause coronary vasospasm, a rare but serious reaction. This complication should be considered in patients with ovarian cancer experiencing sudden cardiac changes during treatment.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Advanced ovarian carcinoma treatment often involves chemotherapy regimens like carboplatin and cyclophosphamide.
- Patient monitoring during chemotherapy infusion is crucial for detecting adverse events.
- Understanding drug-induced cardiovascular complications is essential for patient safety.
Observation:
- A 68-year-old female patient with advanced ovarian carcinoma experienced collapse during a carboplatin and cyclophosphamide infusion.
- The patient's collapse was clinically assessed as consistent with coronary vasospasm.
- Electrocardiogram (ECG) showed hyperacute changes indicative of cardiac distress.
Findings:
- The observed reaction suggests a potential hypersensitivity to carboplatin.
- Carboplatin-induced hypersensitivity can manifest as acute cardiovascular events, including coronary vasospasm.
- This case highlights a rare but significant adverse effect of carboplatin therapy.
Implications:
- Clinicians should consider carboplatin hypersensitivity in patients with ovarian cancer presenting with acute ECG changes during treatment.
- Early recognition and management of carboplatin-induced coronary vasospasm are critical.
- This underscores the importance of vigilance for rare drug reactions in oncology practice.